EquityFlow › Companies › Sapreme Technologies

Sapreme Technologies

Biotech · Utrecht, NL

Biotech improving delivery of macromolecule cancer therapeutics.

Funding history

DateRoundAmount
Oct 2021Series A
Utrecht biotech Sapreme Technologies raised a EUR 15M Series A led by Aglaia Oncology Funds.
$17.7M

Investors

Aglaia Oncology Funds

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →